BRIEF-Spruce Biosciences On March 16, Entered Termination Agreement With Kaken Pharmaceutical - SEC Filing
Spruce Biosciences, Inc. -3.61% Post
Spruce Biosciences, Inc. SPRB | 63.63 63.63 | -3.61% 0.00% Post |
March 20 (Reuters) - SEC Filing:
SPRUCE BIOSCIENCES INC - ON MARCH 16, ENTERED TERMINATION AGREEMENT WITH KAKEN PHARMACEUTICAL - SEC FILING
SPRUCE BIOSCIENCES INC - COLLABORATION AGREEMENT WITH KAKEN PHARMACEUTICAL TO TERMINATE EFFECTIVE MARCH 31, 2026 - SEC FILING
SPRUCE BIOSCIENCES INC - ALL LICENSES & RIGHTS GRANTED BY CO TO KAKEN TO BE TERMINATDE; NO UNEARNED MILESTONE PAYMENTS OR ROYALTIES
Source text: [ID:n0001193125-26-117888]
Further company coverage: SPRB.O
